Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II randomized, observer-blind, active-controlled study to evaluate the immunogenicity and safety of a single dose of BioNet-Asiaâ??s acellular pertussis-only vaccine and its combined tetanus-diphtheria-acellular pertussis vaccine at multiple

Trial Profile

A phase II randomized, observer-blind, active-controlled study to evaluate the immunogenicity and safety of a single dose of BioNet-Asiaâ??s acellular pertussis-only vaccine and its combined tetanus-diphtheria-acellular pertussis vaccine at multiple

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Pertussis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top